Lambda has been detected in 29 countries with high prevalence in Peru (81% of cases) and Argentina (37%), but scientists say it poses less concern than the Delta variant. Lab studies show vaccine antibodies are less potent against Lambda than original strain, yet vaccines retain neutralizing capacity and T-cells provide additional immune protection.
O GLOBO
· Jul 10, 2021
· health
· 3 min de lectura
Medium
Verificación: Caracterizado
Lambda variant spreads in South America as scientists seek answers on vaccine efficacy
Three confirmed cases and one death linked to Lambda variant in Brazil; regional spread accelerating across South America.
◉
Health & Medicine
2792 artículos relacionados
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% coincidencia
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% coincidencia
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% coincidencia
Retatrutida achieves 30% weight loss in landmark obesity study
Veja Saúde · 90% coincidencia
Medical Expert Warns of Tirzepatide Risks, Emphasizes Need for Profess…
UNIPAR · 90% coincidencia
Cobertura Relacionada
O POVO · Aug 23
Dia D mobiliza Fortaleza com multivacinação e mutirão bucal em 264 locais
Fortaleza realizou mobilização massiva de imunização com 3 mil profissionais em 264 locais, incluindo multivacinação, mu…
Folha de S.Paulo · Aug 23 Tratar apneia do sono pode reduzir pressão arterial em hipertensosEstudo brasileiro demonstra que tratar apneia obstrutiva do sono contribui para reduzir hipertensão resistente, mesmo em…
Rádio Pampa · Aug 23 Duas em cada três pessoas com Alzheimer são mulheres; sintomas podem começar aos 45Pesquisa mostra que duas em cada três pessoas com Alzheimer são mulheres, com sintomas podendo começar aos 45 anos devid…
Rádio Pampa · Aug 23 Dieta rica em vegetais reduz risco de doença renal crônica, aponta estudoEstudo com 179.508 participantes mostra que dieta rica em vegetais, frutas e grãos integrais reduz risco de doença renal…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
Lambda COVID-19 variant spreads across South America with preliminary evidence suggesting vaccine efficacy, but limited genomic surveillance capacity hampers definitive assessment of transmissibility and severity.
Escalation Risk
low
Confidence
MED
Brazil
Peru
Argentina
Chile
South America
Latin America
Reveals structural inequalities in global health infrastructure; wealthy nations with robust genomic surveillance gain epidemiological advantage, while South American countries face capacity constraints limiting their ability to independently assess and respond to variants, potentially increasing dependence on WHO guidance and external expertise.
Similar to 2009 H1N1 pandemic response, where developing nations struggled with surveillance and response capabilities, creating information asymmetries that affected policy decisions and vaccine distribution equity.
Lente Económico
📈
Lambda COVID-19 variant spreading in South America with preliminary evidence suggesting existing vaccines may provide neutralization, but definitive efficacy data remains unavailable, creating economic uncertainty.
Market Signal
mixed
Confidence
MED
Healthcare and pharmaceuticals
Tourism and hospitality
Retail and consumer services
Transportation and logistics
Manufacturing and supply chains
Consumers face renewed uncertainty regarding pandemic duration and travel restrictions. Potential for increased healthcare costs, delayed economic reopening in affected regions, and continued disruption to leisure and travel spending in South America.
Governments may implement renewed travel restrictions or quarantine measures; increased pressure on vaccine distribution and genomic surveillance infrastructure; potential for coordinated regional health policy responses; possible delays in economic reopening timelines in South America.